Clinical trial
Oral Vitamin K2 (Menaquinone-7; MK-7) Supplementation and Effect on Vitamin K Status of Breastfed Term Infants in Early Infancy; a Four-cohort Prospective, Part-randomised, Part-blinded Study.
NCT07620236 is registered in ClinicalTrials.gov with Norfolk and Norwich University Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Vitamin K2 (Menaquinone-7; MK-7) Supplementation and Effect on Vitamin K Status of Breastfed Term Infants in Early Infancy; a Four-cohort Prospective, Part-randomised, Part-blinded Study.
- Lead sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- August 1, 2028
- Enrollment
- 134 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
infant vitamin k status, vitamin k deficiency bleeding